Sotera Health Company
SHC
$17.15
$0.543.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.12B | 1.11B | 1.10B | 1.12B | 1.10B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.12B | 1.11B | 1.10B | 1.12B | 1.10B |
| Cost of Revenue | 500.09M | 496.18M | 498.15M | 502.46M | 492.21M |
| Gross Profit | 624.44M | 610.61M | 602.30M | 618.01M | 605.97M |
| SG&A Expenses | 205.30M | 203.44M | 204.75M | 202.29M | 194.29M |
| Depreciation & Amortization | 55.52M | 61.63M | 62.04M | 62.36M | 62.62M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 760.90M | 761.25M | 764.93M | 767.12M | 749.12M |
| Operating Income | 363.63M | 345.54M | 335.51M | 353.36M | 349.06M |
| Income Before Tax | 91.79M | 88.04M | 113.87M | 134.58M | 92.30M |
| Income Tax Expenses | 67.77M | 63.22M | 69.48M | 63.82M | 52.20M |
| Earnings from Continuing Operations | 24.02 | 24.82 | 44.40 | 70.76 | 40.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.02M | 24.82M | 44.40M | 70.76M | 40.10M |
| EBIT | 363.63M | 345.54M | 335.51M | 353.36M | 349.06M |
| EBITDA | 525.32M | 512.12M | 501.78M | 520.05M | 510.79M |
| EPS Basic | 0.08 | 0.09 | 0.16 | 0.25 | 0.14 |
| Normalized Basic EPS | 0.44 | 0.40 | 0.38 | 0.42 | 0.41 |
| EPS Diluted | 0.08 | 0.08 | 0.15 | 0.25 | 0.14 |
| Normalized Diluted EPS | 0.44 | 0.40 | 0.37 | 0.42 | 0.41 |
| Average Basic Shares Outstanding | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B |
| Average Diluted Shares Outstanding | 1.14B | 1.14B | 1.14B | 1.14B | 1.13B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |